Free Submission Public Relations & NewsPR-inside.com
Home
Deutsch English

Business

New Market Report: Celldex Therapeutics, Inc. - SWOT, Strategy and Corporate Finance Report


Print article Print article
2013-12-27 15:14:37 - Recently published research from MarketLine, "Celldex Therapeutics, Inc. - SWOT, Strategy and Corporate Finance Report", is now available at Fast Market Research

Celldex Therapeutics, Inc. - SWOT, Strategy and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings, detailed financials, and corporate actions, providing a 360deg view of the company.

Features:

* Detailed information on Celldex Therapeutics, Inc. required for business and competitor intelligence needs
* A study of the major internal and external factors affecting Celldex Therapeutics, Inc. in the form of a SWOT analysis
* An in-depth view of the business model of Celldex Therapeutics, Inc. including a breakdown and examination of key business segments
* Five-year financial information and charts, including balance sheet, income statement, cash flows, market capitalization and multiples, and key ratios

for Celldex Therapeutics, Inc.
* Intelligence on Celldex Therapeutics, Inc.nv's mergers and acquisitions (M&A), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
* News about Celldex Therapeutics, Inc., such as business expansion, restructuring, and contract wins
* Large number of easy-to-grasp charts and graphs that present important data and key trends

Full Report Details at
- www.fastmr.com/prod/757361_celldex_therapeutics_inc_swot_strateg ..

Highlights:

Celldex Therapeutics (Celldex or 'the company') is a development-stage biopharmaceutical company. The company operates in the US. It is headquartered in Needham, Massachusetts, and employed 112 people (of which six were part-time employees) as on December 31, 2012. The company recorded revenues of $11.2 million during the financial year ended December 2012 (FY2012), an increase of 20.9% over FY2011. The operating loss of the company was $58.1 million during FY2012, as compared to an operating loss of $43.4 million in FY2011. The net loss was $59.1 million in FY2012, as compared to a net loss of $44.8 million in FY2011.

Reasons to Purchase:

* Gain understanding of Celldex Therapeutics, Inc. and the factors that influence its strategies
* Track strategic initiatives of the company and latest corporate news and actions
* Assess Celldex Therapeutics, Inc. as a prospective partner, vendor or supplier
* Support sales activities by understanding your customers' businesses better
* Stay up to date on Celldex Therapeutics, Inc.'s business structure, strategy and prospects

Partial Table of Contents:

Company Snapshot
Celldex Therapeutics, Inc.: Company Overview
Celldex Therapeutics, Inc.: Overview and Key Facts
Celldex Therapeutics, Inc.: Overview
Celldex Therapeutics, Inc.: Key Facts
Celldex Therapeutics, Inc.: Key Employees
Celldex Therapeutics, Inc.: Key Employee Biographies
Celldex Therapeutics, Inc.: Major Products and Services
Celldex Therapeutics, Inc.: Company History
Celldex Therapeutics, Inc.: Management Statement
Celldex Therapeutics, Inc.: Locations and Subsidiaries
Celldex Therapeutics, Inc.: Key Competitors
Celldex Therapeutics, Inc.: Company Analysis
Celldex Therapeutics, Inc.: Business Description
Celldex Therapeutics, Inc.: SWOT Analysis
Celldex Therapeutics, Inc.: SWOT Overview
Celldex Therapeutics, Inc.: Strengths
Celldex Therapeutics, Inc.: Weaknesses
Celldex Therapeutics, Inc.: Opportunities
Celldex Therapeutics, Inc.: Threats
Celldex Therapeutics, Inc.: Corporate Financial Deals Activity
Celldex Therapeutics, Inc.: Financial Deals Overview
Celldex Therapeutics, Inc.: Targets and Partners
Celldex Therapeutics, Inc.: Top Deals 2009 - 2013YTD*
Celldex Therapeutics, Inc.: Advisors
Celldex Therapeutics, Inc.: Top Legal Advisors
Celldex Therapeutics, Inc.: Top Financial Advisors
Celldex Therapeutics, Inc.: Mergers and Acquisitions
Celldex Therapeutics, Inc.: Capital Raising
Celldex Therapeutics, Inc.: Partnership
Celldex Therapeutics, Inc.: Divestments
Celldex Therapeutics, Inc.: Recent Developments
Celldex Therapeutics, Inc.: News and Events Summary
Celldex Therapeutics, Inc.: Contracts
Celldex Therapeutics, Inc.: Corporate Governance
Celldex Therapeutics, Inc.: Financial Deals
Celldex Therapeutics, Inc.: Financial Performance
Celldex Therapeutics, Inc.: Research & Development
Appendix
Contact Us
Methodology
Definitions
About Datamonitor

List of Tables

Table 1: Celldex Therapeutics, Inc.: Key Facts
Table 2: Celldex Therapeutics, Inc.: Key Employees
Table 4: Celldex Therapeutics, Inc.: Key Competitors
Table 5: Celldex Therapeutics, Inc.: Deal Activity by Deal Type - Volume (TTM*)
Table 6: Celldex Therapeutics, Inc.: Deal Activity by Deal Type - Volume (2009 - YTD*2013)
Table 7: Celldex Therapeutics, Inc.: M&A Average Deal Size - Value (US$m)
Table 8: Celldex Therapeutics, Inc.: Targets and Partners
Table 9: Celldex Therapeutics, Inc.: Top Deals 2009 - 2013YTD*
Table 10: Celldex Therapeutics, Inc.: Legal Advisor Ranking by Value (US$m)
Table 11: Celldex Therapeutics, Inc.: Financial Advisor Ranking by Value (US$m)
Table 12: Celldex Therapeutics, Inc.: M&A Volume and Value Trend (2009 - YTD*2013)
Table 13: Celldex Therapeutics, Inc.: M&A Activity by Geography (2009 - YTD*2013)
Table 14: Celldex Therapeutics, Inc.: Capital Raising Volume and Value Trend (2009 - YTD*2013)
Table 15: Celldex Therapeutics, Inc.: Capital Raising by Deal Type (2009 - YTD*2013)
Table 16: Celldex Therapeutics, Inc.: Partnership Volume and Value Trend (2009 - YTD*2013)
Table 17: Celldex Therapeutics, Inc.: Partnership Trend by Deal Type (2009 - YTD*2013)
Table 18: Celldex Therapeutics, Inc.: Divestments Volume and Value Trend (2009 - YTD*2013)
Table 19: Celldex Therapeutics, Inc.: Divestments by Geography (2009 - YTD*2013)

Full Table of Contents is available at:
-- www.fastmr.com/catalog/product.aspx?productid=757361&dt=t

About MarketLine

MarketLine is a global publisher of company, industry and country information. Their clients operate across a wide variety of industries and job functions and range from multinational corporations right down to small businesses in both developed and developing economies. MarketLine users enjoy access to content that is trustworthy, up to date and reasonably priced and routinely turn to them as their first-stop resource for instantly accessible, reliable business information. View more research from MarketLine at www.fastmr.com/catalog/publishers.aspx?pubid=1034

About Fast Market Research

Fast Market Research is an online aggregator and distributor of market research and business information. We represent the world's top research publishers and analysts and provide quick and easy access to the best competitive intelligence available.

For more information about these or related research reports, please visit our website at www.fastmr.com or call us at 1.800.844.8156.


Author:
Bill Thompson
e-mail
Web: www.fastmr.com
Phone: 18008448156

Disclaimer: If you have any questions regarding information in these press releases please contact the company added in the press release. Please do not contact pr-inside. We will not be able to assist you. PR-inside disclaims contents contained in this release.
Latest News
Read the Latest News
www.newsenvoy.com

 


Terms & Conditions | Privacy | About us | Contact PR-inside.com